|
|
Europe
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement. |
In Gleevec Feud, Novartis Targets Indian Patent Rules
Friday, August 18, 2006
In its ongoing battle to patent its cancer treatment Gleevec in India, Novartis AG has lashed out not only at the rejection of its patent application earlier this year, but at a key section of India’s recently enacted patent laws. |
Jury Bats Down Synthon’s Claim Against Pfizer
Friday, August 18, 2006
In another victory for brand name drug companies, a federal jury has rejected Dutch generics maker Synthon IP Inc.’s claim that Pfizer Inc.’s blockbuster blood pressure drug Norvasc violates its intellectual property. |
Bristol-Myers, Sanofi Try To Cope With Generic Plavix
Wednesday, August 16, 2006
In an attempt to cope with Apotex Inc.’s recent launch of generic Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA are offering the buyers of Plavix prices below the price of the generic version. |
In HIV/AIDS Fight, Tough Choices Loom For Thailand
Wednesday, August 16, 2006
Weeks after protestors rallied against British drug maker GlaxoSmithKline’s efforts to patent an anti-retroviral in Thailand, the World Bank warned in a report Wednesday that the country must decide whether to shell out market prices for patented drugs as a rising number of Thais living with HIV/AIDS are forced to turn to so-called second-line drugs. |
Abbott Slashes HIV Drug Price For Developing Nations
Tuesday, August 15, 2006
Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world. |
Judge Extends Deadline In Qualcomm-Broadcom Spat
Tuesday, August 15, 2006
The complicated ongoing legal wrangling between communications company Qualcomm Inc. and wireless semiconductor maker Broadcom Corp. slowed this week, with an administrative law judge opting to postpone a decision due to the complexity of the issues raised in the patent infringement case. |
Novartis Challenges Gleevec Patent Block In India
Monday, August 14, 2006
Less than a year after India’s Patent Controller denied Novartis AG's patent application for the cancer treatment Gleevec, the Swiss-based pharmaceutical company is railing against the rejection. |
Sanofi, Bristol-Myers Fire Back In Plavix Feud
Monday, August 14, 2006
Hot on the heels of Apotex’ launch of an at-risk generic version of Plavix earlier this month, Sanofi-Aventis and Bristol-Myers Squibb are lashing out at the generic drug maker, filing a motion for a preliminary injunction on Monday in an attempt to block Apotex’ copycat version of the blood thinner. |
Apotex Launches At-Risk Generic Plavix
Tuesday, August 08, 2006
Much to the horror of Bristol-Myers Squibb and Sanofi-Aventis, Apotex officially launched an at-risk generic version of Plavix on Tuesday after the settlement between the three companies over the patent failed to receive antitrust clearance. |
Altana And Wyeth Strike Again Over Protonix
Tuesday, August 08, 2006
German drug maker Altana Pharma AG and its U.S. partner, Wyeth Pharmaceuticals, expanded a long-running legal campaign Tuesday with another patent infringement lawsuit over their multi-billion dollar heartburn drug Protoxin. |
Inventor Falsified Experiment, Federal Circuit Says
Monday, August 07, 2006
A district court’s ruling of inequitable conduct has been upheld, rendering four Housey Pharmaceuticals Inc. patents unenforceable in a patent infringement case brought by Bayer AG. |
KCI Wound-Healing Patent Not Infringed, Judge Rules
Friday, August 04, 2006
A federal court has dealt a blow to medical equipment maker Kinetic Concepts Inc., ruling that rival company BlueSky Medical Group Inc. did not infringe a Kinetic patent for a wound-healing device. |
Rambus Ruling Watched Closely By Chip Makers
Friday, August 04, 2006
The legal landscape may look bleak for Rambus Inc. after the U.S. Federal Trade Commission’s recent antitrust ruling against the technology-licensing company, but Rambus is confident the decision isn’t a death-knell for its related cases. |
Alcatel Accused Of Duping Standard-Setting Body
Thursday, August 03, 2006
Alcatel SA, the French telecommunications giant, duped a global standard-setting body into adopting industrywide standards without disclosing that it held patent applications for the technology, according to a federal antitrust lawsuit filed this week. |
Apple Responds to Scandinavian Antitrust Inquiry
Wednesday, August 02, 2006
Apple Computer Inc. has met a deadline imposed by a Scandinavian federal consumer agency to respond to claims that it is violating antitrust laws by not making songs purchased on its online music store compatible with other brands’ mp3 players. |
Plavix Patent Litigation to Resume, Sanofi Exec Says
Wednesday, August 02, 2006
Patent litigation between Sanofi-Aventis S.A., Bristol-Myers Squibb and Apotex Corp. over a generic version of the blood thinner Plavix will be reinstated, Sanofi Chief Financial Officer Jean-Claude Leroy said on Wednesday. |
Ericsson Takes Aim At Samsung Over Phone Patents
Tuesday, August 01, 2006
Taking the offensive against South Korean Samsung Electronics Co. Ltd. once again, Swedish handset maker Ericsson Inc. has brought an infringement suit, alleging its rival has violated 11 of its mobile communication patents. |
Drug Cos. Hit With Plavix Antitrust Class Action
Tuesday, August 01, 2006
Pharmaceutical giants Bristol-Myers Squibb Co., Sanofi-Aventis and Apotex Corp. were served with two antitrust class actions on Monday over their controversial Plavix settlement agreement. |
State Attorneys General Reject Revised Plavix Deal
Monday, July 31, 2006
For the second time, Bristol-Myers Squibb and Sanofi-Aventis have failed to get antitrust clearance for the Plavix litigation settlement from state attorneys general. |
 |
French Tax Raises Money For Drugs—And IP Concerns
As international governments and drug companies struggle to find a balance between protection of intellectual property and the rights of poor nations to access crucial medications, a controversial new French initiative stands to fuel the growing debate by pressuring the pharmaceutical industry to lower its prices. |
|
Latest Articles
London Fog Lets Go Of Trademark
Monday, August 21, 2006
Still selling off its assets, bankrupt rainwear maker London Fog Group Inc. has unloaded its famed trademark, with Iconix Brand Group Inc. snapping up the recognizable brand for $30.5 million in cash and $7 million in stock.
|
No End In Sight In Plavix Battle
Monday, August 21, 2006
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.
|
Lengthy Patent Battle Wages On For Microsoft
Monday, August 21, 2006
Timeline Inc. announced Monday that it has terminated a limited license with Microsoft Corp. for use of its patents with the software giant’s SQL Servers, and has asked a federal court to add Microsoft to a patent infringement lawsuit.
|
eBay Opinion Doesn’t Affect Preliminary Injunctions, Judge Rules
Monday, August 21, 2006
A federal judge has ruled that a landmark Supreme Court decision involving eBay only relates to permanent injunctions and not preliminary ones.
|
Federal Circuit Overturns Jury Verdict Against ACell
Monday, August 21, 2006
The Federal Circuit has overturned a jury verdict that found biotechnology company ACell Inc. liable for patent infringement of a tissue-engineering method for healing wounds and scars, ruling against Cook Biotech Inc. and Purdue Research Foundation.
|
Silicon Graphics To Retain Paul Hastings
Monday, August 21, 2006
Silicon Graphics Inc. has requested permission to hire Paul, Hastings, Janofsky & Walker LLP to act as its special intellectual property counsel.
|
Courts Write History on Permanent Injunctions In Patent Actions
Monday, August 21, 2006
Although a few more pages have been filled on the subject, there are still more pages that need to be written before the full impact and proper manner of applying the logic set forth in eBay will be understood, say Anthony F. Lo Cicero and Charles R. Macedo of Amster, Rothstein & Ebenstein LLP.
|
DexCom Scores Stay, Partial Dismissal In Abbott Suit
Friday, August 18, 2006
DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics.
|
EchoStar Wins Block Of Damaging DVR Injunction
Friday, August 18, 2006
The U.S. Courts of Appeals for the Federal Circuit Friday blocked a temporary injunction that would have prevented Echostar Communication Corp. from selling some of its digitial video recorders and stopped the service of about 4 million DVRs within 30 days.
|
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
|
|
|
